MdmX inhibits Smad transactivation

Madhavi Kadakia1, Thomas L Brown, Molly M McGorry

  • 1Department of Biochemistry and Molecular Biology, Wright State University, Dayton, Ohio, USA.

Oncogene
|December 17, 2002
PubMed

Insights

MdmX protein inhibits Smad-induced transactivation, a key part of TGF-beta signaling, by interacting with the coactivator p300. This finding offers new insights into cancer growth regulation pathways.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Mdm2 overexpression promotes cell growth by downregulating p53.
  • Mdm2 deregulation can inhibit TGF-beta growth repression independently of p53.
  • Smads are key downstream signaling elements of the TGF-beta pathway.

Purpose of the Study:

  • To investigate if Mdm2 or MdmX overexpression affects Smad-induced transactivation.
  • To determine the mechanism by which MdmX influences Smad activity.

Main Methods:

  • Deletion mutant analysis of MdmX.
  • Overexpression studies in TGF-beta sensitive HepG2 cells.
  • Analysis of Smad transactivation in mouse embryo fibroblasts (MEFs) lacking p53 and/or MdmX.
  • In vitro binding assays.

Main Results:

  • MdmX, but not Mdm2, inhibits Smad-induced transactivation.
  • MdmX inhibition requires amino acid residues 128-444 and is independent of p53 and Mdm2 interaction domains.
  • MdmX overexpression inhibits TGF-beta induced Smad transactivation in HepG2 cells.
  • MEFs lacking p53 and MdmX show enhanced Smad transactivation compared to other knockout lines.
  • p300 reverses MdmX-mediated inhibition of Smad transactivation.
  • MdmX binds to p300, Smad3, and Smad4.

Conclusions:

  • MdmX inhibits Smad-induced transactivation through a mechanism involving its interaction with the coactivator p300.
  • This interaction likely alters the ability of Smads to interact with p300, impacting TGF-beta signaling.
  • The findings suggest a novel role for MdmX in regulating TGF-beta pathway activity, independent of its interaction with p53.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...